Search - tctmd.com

Displaying 121 - 140 of 426

Sort: Relevancy | Date

News Daily News

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Michael O'Riordan

June 13, 2016

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

News Conference News EAS 2016

Non-HDL Cholesterol, Inflammation Appear to Be Linked in Patients Undergoing Elective PCI

Yael L. Maxwell

June 08, 2016

News Conference News EAS 2016

Nutrition and Physical Activity: The ‘Low-Hanging Fruit’ for Cardiologists Programmed to Prescribe Pills

Yael L. Maxwell

June 07, 2016

News Conference News EAS 2016

Preservation of LDL Cholesterol Targets for Lipid Lowering in New European Guidance Gets Blessing of Prevention Experts

Yael L. Maxwell

June 06, 2016

News Daily News

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Todd Neale

May 27, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Shelley Wood

May 18, 2016

News Daily News

粥样硬化性心血管疾病计算器是否会高估患者的风险？争论还在继续

Yael L. Maxwell

May 04, 2016

News Daily News

El Debate Sigue Abierto: ¿Sobrevalora la Calculadora de la Enfermedad Cardiovascular Aterosclerótica el Riesgo de los Pacientes?

Yael L. Maxwell

May 04, 2016

News Daily News

Does the Atherosclerotic Cardiovascular Disease Calculator Overestimate Patient Risk? The Debate Continues

Yael L. Maxwell

May 04, 2016

News Daily News

Higher Consumption of Sugar-Sweetened Beverages Linked With Greater Coronary Artery Calcium

Leah Lawrence

April 26, 2016

Presentation Fellows 2016

Plaque Modification Devices and Coronary Atherectomy

Presenter: Dimitrios Karmpaliotis, Jeffrey W. Moses

April 16, 2016

Presentation Fellows 2016

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Presenter: Kevin Croce

April 15, 2016

News Conference News ACC 2016

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

Michael O'Riordan

April 03, 2016

News Daily News

ACC 更新降低低密度脂蛋白胆固醇降低的建议，为依折麦布和 PCSK9 抑制剂留出了空间

Michael O'Riordan

April 02, 2016

News Daily News

ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors

Michael O'Riordan

April 02, 2016

News Daily News

ACC actualiza las recomendaciones para bajar el colesterol LBD, abriendo un espacio para el uso de Ezetimibe y de los inhibidores de PCSK9

Michael O'Riordan

April 02, 2016

Presentation CHIP Florida 2016

Importance of Coronary Calcification in Complex PCI:Data and Devices

Presenter: Gregg W. Stone

April 01, 2016

News Daily News

CAD Extent May Foreshadow Risk of Heart Failure After First MI

L.A. McKeown

March 31, 2016

Presentation

Atherosclerotic Burden and Heart FailureAfter Myocardial Infarction

Presenter: Yariv Gerber

March 31, 2016

Advertisement

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Non-HDL Cholesterol, Inflammation Appear to Be Linked in Patients Undergoing Elective PCI

Nutrition and Physical Activity: The ‘Low-Hanging Fruit’ for Cardiologists Programmed to Prescribe Pills

Preservation of LDL Cholesterol Targets for Lipid Lowering in New European Guidance Gets Blessing of Prevention Experts

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

粥样硬化性心血管疾病计算器是否会高估患者的风险？争论还在继续

El Debate Sigue Abierto: ¿Sobrevalora la Calculadora de la Enfermedad Cardiovascular Aterosclerótica el Riesgo de los Pacientes?

Does the Atherosclerotic Cardiovascular Disease Calculator Overestimate Patient Risk? The Debate Continues

Higher Consumption of Sugar-Sweetened Beverages Linked With Greater Coronary Artery Calcium

Plaque Modification Devices and Coronary Atherectomy

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

ACC 更新降低低密度脂蛋白胆固醇降低的建议，为依折麦布和 PCSK9 抑制剂留出了空间

ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors

ACC actualiza las recomendaciones para bajar el colesterol LBD, abriendo un espacio para el uso de Ezetimibe y de los inhibidores de PCSK9

Importance of Coronary Calcification in Complex PCI:Data and Devices

CAD Extent May Foreshadow Risk of Heart Failure After First MI

Atherosclerotic Burden and Heart FailureAfter Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content